Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer [NA]
A terminated clinical trial evaluated a triple antiemetic regimen (granisetron, aprepitant, and dexamethasone) to prevent chemotherapy-induc…
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of topotecan for recurrent ovarian epithelial cancer or primary peritoneal cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-04-10Clinical Trial Update: Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy
This clinical trial update reports on the genomic profiling of residual disease in advanced ovarian cancer after neoadjuvant chemotherapy. T…
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer [Phase 2]
Phase 2 trial evaluating weekly paclitaxel with or without pazopanib in platinum-resistant or refractory ovarian cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer
An observational study evaluating the combination of YONDELIS (trabectedin) plus pegylated liposomal doxorubicin for platinum-sensitive recu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer [Phase 2]
Phase II multi-institutional study evaluating cyclophosphamide, paclitaxel, and cisplatin with G-CSF in newly diagnosed advanced-stage ovari…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer [Phase 1]
Phase 1 trial evaluating copper-64 DOTA-B-Fab for PET/CT imaging in patients with ovarian and breast cancer; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: Dose-finding Study in Platinum-Resistant Ovarian Cancer [Phase 1, Phase 2]
A dose-finding study in recurrent platinum-resistant ovarian cancer completed Phase 1/Phase 2 with results posted.
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for a vaccine therapy in epithelial ovarian, fallopian tube, or peritoneal cancer has completed recruitment wi…
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Photoacoustic Imaging of the Ovary [NA]
This clinical trial assessing photoacoustic imaging of the ovary for ovarian cancer by UConn Health was terminated, with results posted on 2…
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas [Phase 2, Phase 3]
This clinical trial update reports the completion of Phase 2 and Phase 3 testing evaluating drug sensitivity in ovarian, fallopian tube, and…
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: A Study Evaluating MM-310 in Patients With Solid Tumors [Phase 1]
This update reports a Phase 1 study evaluating MM-310 in patients with solid tumors. The listed indications include urothelial carcinoma, ga…
-
CLINICAL_TRIALS trial_result · 2018-02-19Clinical Trial Update: Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial evaluating diet and physical activity changes versus usual care for improving progression-free survival in previously treated …
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy [Phase 3]
A Phase 3 trial evaluating olaparib as maintenance therapy in BRCA-mutated, platinum-sensitive ovarian cancer patients who achieved complete…
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy [NA]
This clinical trial update assesses thermal spread into the interstitial portion of the fallopian tubes when using the Ligasure device durin…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 3]
Phase 3 clinical trial evaluating Paclitaxel and Carboplatin with or without Bevacizumab in Stage II-IV ovarian epithelial cancer, primary p…
-
CLINICAL_TRIALS trial_result · 2018-01-19Clinical Trial Update: Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating carboplatin/pralatrexate in recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer co…
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: A Study of Apatinib Treatment in for Advanced Ovarian Cancer [Phase 2]
Phase 2 trial update for apatinib in advanced ovarian cancer, with unclear current status.
-
CLINICAL_TRIALS trial_result · 2018-01-11Clinical Trial Update: AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of AMG 706 in persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer was termi…
-
CLINICAL_TRIALS trial_result · 2018-01-05Clinical Trial Update: A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer [Phase 2]
Phase II study evaluating the interaction of lovastatin and paclitaxel in patients with refractory or relapsed ovarian cancer; study termina…
-
CLINICAL_TRIALS trial_result · 2018-01-05Clinical Trial Update: Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer [Phase 2]
Phase 2 trial evaluating the effect of flutamide on biomarkers in blood and tissue from patients at high risk for ovarian cancer; results ha…
-
CLINICAL_TRIALS trial_result · 2018-01-03Clinical Trial Update: Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating acetylcysteine with topotecan hydrochloride in patients with persistent or recurrent high-grade ovarian, fallopian …
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube or Primary Peritoneal Carcinoma [Phase 3]
Phase 3 clinical trial evaluating cytoreduction with or without intraoperative intraperitoneal hyperthermic chemotherapy (HIPEC) for periton…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer [Phase 2]
Phase 2 trial of Antineoplaston Therapy for Stage III or Stage IV ovarian cancer was terminated. The sponsor was Burzynski Research Institut…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: A Mind-body Intervention to Improve Body and/or Self Image [NA]
A completed clinical trial evaluating a mind-body intervention to improve body image and self-image in women with breast cancer, ovarian can…